Results 231 to 240 of about 18,617,874 (263)

When Does SDG Adoption Increase ESG Risk? The Mediating Role of Risk Management

open access: yesBusiness Strategy and the Environment, EarlyView.
ABSTRACT Corporate engagement with the United Nations' Sustainable Development Goals (SDGs) has expanded rapidly, yet its implications for firms' environmental, social and governance (ESG) risk remain insufficiently understood. Prior research has focused on the performance outcomes of SDG adoption while largely overlooking its potential to generate ESG
Francisco J. López‐Arceiz   +1 more
wiley   +1 more source

Mitigating the Heat: The Role of AI Technology in Shielding Corporate Environmental Performance From Extreme Temperatures—Difference‐in‐Differences Evidence From Chinese Listed Firms

open access: yesBusiness Strategy and the Environment, EarlyView.
ABSTRACT Extreme heat has become a recurring operational challenge that disrupts production, raises energy and maintenance needs, and makes it harder for firms to sustain environmental performance. However, it remains less clear whether AI‐related capability is associated with firms' ability to maintain environmental performance under recurring extreme‐
Shangze Dai, Xinde James Ji, Kai Huang
wiley   +1 more source

A Comparison of Open-Label and Deceptive Placebo Analgesia in a Healthy Sample [PDF]

open access: yesJournal of Psychosomatic Research, 2021
A small number of studies have supported the efficacy of open-label placebos (OLPs) in reducing pain. However, research comparing the effectiveness of OLPs with deceptive placebos (DPs) is limited, and the relative impact on pain tolerance versus intensity are not yet understood.
Susanna Kola, Chris Retzler
exaly   +3 more sources

The Role of Positive Information Provision in Open-Label Placebo Effects

open access: yesApplied Psychology: Health and Well-Being, 2023
Abstract Open label placebos (OLPs) appear generally efficacious among clinical samples, but the empirical evidence regarding their use in non‐clinical and sub‐clinical samples, as well as when administered independent of a convincing rationale, is mixed. Healthy participants ( N
Kirsten Barnes, Kate Faasse
exaly   +3 more sources

Open-Label Placebos for Wound Healing: A Randomized Controlled Trial [PDF]

open access: yesAnnals of Behavioral Medicine, 2018
Open-label placebos are a novel treatment option, in which participants take placebos with full knowledge that they do not contain active medicine. Open-label placebo treatments have been shown to result in patient-reported symptom improvements, but they have not been tested on objectively measurable physiological outcomes such as wound healing.The ...
Paul Jarrett   +2 more
exaly   +3 more sources
Some of the next articles are maybe not open access.

Related searches:

Choice over placebo administration enhances open-label placebo hypoalgesia

Pain, 2023
Abstract Many studies indicate that deceptively administered placebos can improve pain outcomes. However, the deception involved presents an ethical barrier to translation because it violates informed consent and patient autonomy. Open-label placebos (OLPs), inert treatments that are openly administered as placebos, have been proposed
Biya Tang, Evan Livesey, Ben Colagiuri
openaire   +2 more sources

Open-Label Placebo Treatment for Experimental Pain: A Randomized-Controlled Trial With Placebo Acupuncture and Placebo Pills

Journal of Integrative and Complementary Medicine, 2022
Objective: An open-label placebo (OLP) is a placebo treatment in which the patient is aware that the treatment is a placebo. OLPs are considered effective for reducing pain, and previous studies have shown a stronger placebo effect for placebo acupuncture than for placebo pills.
Younbyoung Chae   +2 more
exaly   +3 more sources

Deceptive but Not Open Label Placebos Attenuate Motion-Induced Nausea

Journal of Psychosomatic Research, 2019
Nausea is a common complaint, known to respond to the placebo effect. Existing research has employed deception when administering placebos for nausea, limiting therapeutic translation on ethical grounds. We therefore examined the potential of non-deceptive open-label placebos (OLPs) to reduce nausea.Galvanic Vestibular Stimulation (GVS) and Virtual ...
Ben Colagiuri
exaly   +3 more sources

Open-Label Placebo: Reflections on a Research Agenda

Perspectives in Biology and Medicine, 2018
Open-label placebos (OLP)-placebo pills honestly prescribed-have challenged the notion that placebos require either deception or concealment to evoke salubrious benefits. This essay describes how the author arrived at the counter-intuitive OLP hypothesis, discusses evidence for OLP effectiveness, and examines mechanistic explanations for OLP.
openaire   +2 more sources

Open-label nondeceptive placebos

Open-label placebos (OLPs), where patients are informed they are receiving a placebo, challenge the traditional notion that placebos require deception to be effective. Recent research has shown that OLPs can positively impact subjective outcomes, such as pain perception and symptom severity, across various conditions like chronic pain, mental disorders,
Kleine-Borgmann, Julian, Bingel, Ulrike
openaire   +3 more sources

Home - About - Disclaimer - Privacy